Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients

OBJECTIVE: This study compared the safety and efficacy of Safacto(®) versus xyntha(®) in patients with severe hemophilia A. METHODS: Thirty-three male patients with severe hemophilia A were randomly divided into two groups. Seventeen patients received Safacto(®) and 16 patients received Xyntha(®) fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Abolghasemi, Hassan, Panahi, Yunes, Ahmadinejad, Minoo, Toogeh, Gholamreza, Karimi, Mehran, Eghbali, Aziz, Mirbehbahani, Nargess Bigom, Dehdezi, Bighan Keikhaei, Badiee, Zahra, Hoorfar, Hamid, Eshghi, Peyman, Maghsoudi, Nader, Sahebkar, Amirhossein, Gholami-Fesharaki, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pharmacopuncture Institute (KPI) 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054092/
https://www.ncbi.nlm.nih.gov/pubmed/30151307
http://dx.doi.org/10.3831/KPI.2018.21.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054092/
https://www.ncbi.nlm.nih.gov/pubmed/30151307
http://dx.doi.org/10.3831/KPI.2018.21.009

Ejemplares similares